glp-1 and mash glp 1 and Glucagon Receptor Dual Agonists in the Management of Metabolic Dysfunction-associated Steatotic Disease (MASLD) glp 1 approved for mash

Click to view and download diaTribe's helpful infographic on preventing heart disease

A separate 2024 FDA referral and additional 2026 scrutiny around GLP-1 compounding practices may still be unresolved

Exendin-4

Glutathione injections deliver a wide range of health benefits thanks to their powerful antioxidant properties

Its not clear if there is something unique about this class of drugs that leads to specific outcomes on the muscle, whether its a loss of mass or an improvement in muscle function and performance

Once again, over 90% of these cases are T2DM, with the fastest growth expected in low- and middle-income countries